Halozyme Therapeutics (NASDAQ:HALO) Issues FY 2024 Earnings Guidance
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 3.650-4.050 for the period, compared to the consensus EPS estimate of 3.730. The company issued revenue guidance of $935.0 million-$1.0 billion, compared to the consensus revenue estimate of $947.3 million. Halozyme Therapeutics Trading Up […]
More Stories
Global Trade Is Not Ending — It Is Being Reshaped by Geopolitical Competition
Seaports and container terminals remain essential to international commerce, connecting manufacturers, suppliers and consumers across global markets. Photo: Jonathan Thacker...
The AI Investment Boom: Who Will Capture the Economic Benefits?
Data centres provide the computing infrastructure that supports artificial intelligence, cloud services and the digital economy. Photo: Helpameout / Wikimedia...
How to Recover a Disabled Instagram Account? Tips and Process
Losing access to your personal or business Instagram account can disrupt personal connections, professional outreach, or years of memories. Instagram...
How Payment Processing Fees Affect Ecommerce Profit Margins
Card fees take a larger share of an online store’s profit than its revenue line suggests. Publicly traded general retailers...
Ukraine, Russia and Europe: Why the Future of European Security Is at a Turning Point
European diplomacy faces important questions about security, peace and international cooperation. The war in Ukraine continues to shape Europe's political...
COP31: Can World Leaders Turn Climate Promises into Real Action?
Renewable energy investment is central to the international effort to reduce greenhouse gas emissions. Climate change has become one of...
